Tag: price

TALLINN, Estonia, June 07, 2025 (GLOBE NEWSWIRE) -- Bitcoin Solaris (BTC-S), a next-generation blockchain platform engineered for speed, decentralization, and smart contract utility, today announced the final day of Phase 6 of its presale. Priced at $6 per token, this marks the last opportunity for early supporters to participate before the next price increase to $7, with the public launch set at $20.

LEEDS, United Kingdom, June 07, 2025 (GLOBE NEWSWIRE) -- Nimanode, a pioneering protocol building AI-driven autonomous agents on the XRP Ledger (XRPL), has officially launched the presale of its native utility token, $NMA. As the first no-code AI agent builder on XRPL, Nimanode empowers users to deploy, customize, and manage intelligent blockchain agents without writing a single line of code.

Washington, DC, June 06, 2025 (GLOBE NEWSWIRE) --

Link to ThinkCareBelieve's Article:  https://thinkcarebelieve.blog/2025/06/06/week-20-week-20-of-americas-comeback-led-by-president-trump/

Complete Incompetence at the Board Level Results in Fire Sale of Treasured MediPharm Asset, the Hope Facility, to a Competitor

SAN DIEGO, June 06, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Zenas BioPharma, Inc. (NASDAQ: ZBIO) securities pursuant and/or traceable to Zenas BioPharma’s registration statement issued in connection with Zenas BioPharma’s initial public offering (the “IPO”) held on or around September 13, 2024, and were damaged thereby, have until June 16, 2025 to seek appointment as lead plaintiff of the Zenas BioPharma class action lawsuit. Captioned Buathongsri v. Zenas BioPharma, Inc., No. 25-cv-10988 (D. Mass.), the Zenas BioPharma class action lawsuit charges Zenas BioPharma as well as certain of Zenas BioPharma’s top executives and directors, as well as the underwriters of the IPO, with violations of the Securities Act of 1933.

Saskatoon, SK., June 06, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), a drone solutions, and systems developer, today announced that further to the closing of the Company’s US$3.6 million underwritten public offering on May 5, 2025 (the “Offering”), Maxim Group LLC, as underwriter and sole book-running manager, has partially exercised their over-allotment option to purchase an additional 100,000 common shares at the price of US$2.09 per share for aggregate gross proceeds of US$209,000 prior to deducting underwriter discounts and commissions.

Investors can contact the law firm at no cost to learn more about recovering their losses​